Amgen, Inc.: Sensipar (cinacalcet) Tablets, 60mg, 30-count Bottles

Sensipar Recall Summary Amgen is recalling Sensipar (cinacalcet) 60mg tablets in 30-count bottles nationwide due to manufacturing quality control deviations. The affected product was distributed across all U.S. states and was manufactured in Japan. This is a Class II recall, meaning the product could cause adverse health effects or serious problems.

Recalling firm

Amgen, Inc.

Product

Sensipar (cinacalcet) Tablets, 60mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks ,CA 91320-1799, Made in Japan. NDC 55513-074-30

Reason

CGMP Deviations

Classification

Class II

Category

drug recall

Country

United States

Agency

U.S. Food and Drug Administration

Recall date

2026-06-04

Status

Ongoing

Areas affected

AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...

Distribution

Nationwide within the United States

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/af17f1c5-9e82-4ece-8a4e-3b1ae5db98ad